Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis

Status:
Completed

Trial end date:
2007-10-01

Target enrollment:

Participant gender:

This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to Multiple Sclerosis.

Phase 4

NEMA Research, Inc.

Nabilone